Reuters logo
BRIEF-Mabvax Therapeutics enrolls patients in expansion of Phase I clinical trial for pancreatic cancer patients
2016年11月28日 / 下午1点17分 / 10 个月前

BRIEF-Mabvax Therapeutics enrolls patients in expansion of Phase I clinical trial for pancreatic cancer patients

Nov 28 (Reuters) - Mabvax Therapeutics Holdings Inc

* Mabvax Therapeutics enrolls first patients in expansion of Phase I clinical trial treating newly diagnosed pancreatic cancer patients

* Mabvax Therapeutics Holdings says to present results from both dose expansion portions of monotherapy and combination with chemotherapy trials mid-year 2017 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below